BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

110 related articles for article (PubMed ID: 23011840)

  • 1. Auto-threshold quantification of late gadolinium enhancement in patients with acute heart disease.
    Vermes E; Childs H; Carbone I; Barckow P; Friedrich MG
    J Magn Reson Imaging; 2013 Feb; 37(2):382-90. PubMed ID: 23011840
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Accuracy and reproducibility of semi-automated late gadolinium enhancement quantification techniques in patients with hypertrophic cardiomyopathy.
    Mikami Y; Kolman L; Joncas SX; Stirrat J; Scholl D; Rajchl M; Lydell CP; Weeks SG; Howarth AG; White JA
    J Cardiovasc Magn Reson; 2014 Oct; 16(1):85. PubMed ID: 25315701
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comparison of semi-automated methods to quantify infarct size and area at risk by cardiovascular magnetic resonance imaging at 1.5T and 3.0T field strengths.
    Khan JN; Nazir SA; Horsfield MA; Singh A; Kanagala P; Greenwood JP; Gershlick AH; McCann GP
    BMC Res Notes; 2015 Feb; 8():52. PubMed ID: 25889795
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Myocardial infarct sizing by late gadolinium-enhanced MRI: Comparison of manual, full-width at half-maximum, and n-standard deviation methods.
    Zhang L; Huttin O; Marie PY; Felblinger J; Beaumont M; Chillou C; Girerd N; Mandry D
    J Magn Reson Imaging; 2016 Nov; 44(5):1206-1217. PubMed ID: 27096741
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparison of myocardial fibrosis quantification methods by cardiovascular magnetic resonance imaging for risk stratification of patients with suspected myocarditis.
    Gräni C; Eichhorn C; Bière L; Kaneko K; Murthy VL; Agarwal V; Aghayev A; Steigner M; Blankstein R; Jerosch-Herold M; Kwong RY
    J Cardiovasc Magn Reson; 2019 Feb; 21(1):14. PubMed ID: 30813942
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Quantitative analysis of late gadolinium enhancement in hypertrophic cardiomyopathy: comparison of diagnostic performance in myocardial fibrosis between gadobutrol and gadopentetate dimeglumine.
    Liu D; Ma X; Liu J; Zhao L; Chen H; Xu L; Sun Z; Fan Z
    Int J Cardiovasc Imaging; 2017 Aug; 33(8):1191-1200. PubMed ID: 28289991
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comparison of LGE quantitation methods in cardiac sarcoidosis to predict clinical outcomes.
    Benjamin MM; Shah P; Munir MS; Kinno M; Syed MA
    Int J Cardiovasc Imaging; 2023 Mar; 39(3):641-650. PubMed ID: 36424508
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Quantification of late gadolinium enhancement cardiovascular MRI in patients with coronary artery chronic total occlusion.
    Zhang LJ; Dong W; Li JN; Mi HZ; Jiao J; Dou RY; An J; Liu JL; He Y; Song XT
    Clin Radiol; 2020 Aug; 75(8):643.e19-643.e26. PubMed ID: 32418670
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Improvement of late gadolinium enhancement image quality using a deep learning-based reconstruction algorithm and its influence on myocardial scar quantification.
    van der Velde N; Hassing HC; Bakker BJ; Wielopolski PA; Lebel RM; Janich MA; Kardys I; Budde RPJ; Hirsch A
    Eur Radiol; 2021 Jun; 31(6):3846-3855. PubMed ID: 33219845
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Hypertrophic cardiomyopathy: quantification of late gadolinium enhancement with contrast-enhanced cardiovascular MR imaging.
    Harrigan CJ; Peters DC; Gibson CM; Maron BJ; Manning WJ; Maron MS; Appelbaum E
    Radiology; 2011 Jan; 258(1):128-33. PubMed ID: 21045187
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Quantitative T1 Mapping for Detecting Microvascular Obstruction in Reperfused Acute Myocardial Infarction: Comparison with Late Gadolinium Enhancement Imaging.
    Shin JM; Choi EY; Park CH; Han K; Kim TH
    Korean J Radiol; 2020 Aug; 21(8):978-986. PubMed ID: 32677382
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effect of inversion time on the precision of myocardial late gadolinium enhancement quantification evaluated with synthetic inversion recovery MR imaging.
    Varga-Szemes A; van der Geest RJ; Schoepf UJ; Spottiswoode BS; De Cecco CN; Muscogiuri G; Wichmann JL; Mangold S; Fuller SR; Maurovich-Horvat P; Merkely B; Litwin SE; Vliegenthart R; Suranyi P
    Eur Radiol; 2017 Aug; 27(8):3235-3243. PubMed ID: 28050692
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Quantification of infarct size and myocardium at risk: evaluation of different techniques and its implications.
    McAlindon E; Pufulete M; Lawton C; Angelini GD; Bucciarelli-Ducci C
    Eur Heart J Cardiovasc Imaging; 2015 Jul; 16(7):738-46. PubMed ID: 25736308
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Quantitative changes in late gadolinium enhancement at cardiac magnetic resonance in the early phase of acute myocarditis.
    Ammirati E; Moroni F; Sormani P; Peritore A; Milazzo A; Quattrocchi G; Cipriani M; Oliva F; Giannattasio C; Frigerio M; Roghi A; Camici PG; Pedrotti P
    Int J Cardiol; 2017 Mar; 231():216-221. PubMed ID: 27913009
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Automated left ventricle segmentation in late gadolinium-enhanced MRI for objective myocardial scar assessment.
    Tao Q; Piers SR; Lamb HJ; van der Geest RJ
    J Magn Reson Imaging; 2015 Aug; 42(2):390-9. PubMed ID: 25408195
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Age-independent myocardial infarct quantification by signal intensity percent infarct mapping in swine.
    Lenkey Z; Varga-Szemes A; Simor T; van der Geest RJ; Kirschner R; Toth L; Bodnar T; Brott BC; Elgavish A; Elgavish GA
    J Magn Reson Imaging; 2016 Apr; 43(4):911-20. PubMed ID: 26354594
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Differences in quantitative assessment of myocardial scar and gray zone by LGE-CMR imaging using established gray zone protocols.
    Mesubi O; Ego-Osuala K; Jeudy J; Purtilo J; Synowski S; Abutaleb A; Niekoop M; Abdulghani M; Asoglu R; See V; Saliaris A; Shorofsky S; Dickfeld T
    Int J Cardiovasc Imaging; 2015 Feb; 31(2):359-68. PubMed ID: 25352244
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Myocardial Partition Coefficient of Gadolinium: A Pilot Study in Patients With Acute Myocarditis, Chronic Myocardial Infarction, and in Healthy Volunteers.
    Teixeira T; Hafyane T; Jerosch-Herold M; Marcotte F; Mongeon FP
    Can J Cardiol; 2019 Jan; 35(1):51-60. PubMed ID: 30595183
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Determination of regional ejection fraction in patients with myocardial infarction by using merged late gadolinium enhancement and cine MR: feasibility study.
    Masci PG; Dymarkowski S; Rademakers FE; Bogaert J
    Radiology; 2009 Jan; 250(1):50-60. PubMed ID: 19092090
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Validation of sub-segmental visual scoring for the quantification of ischemic and nonischemic myocardial fibrosis using late gadolinium enhancement MRI.
    Fine NM; Tandon S; Kim HW; Shah DJ; Thompson T; Drangova M; White JA
    J Magn Reson Imaging; 2013 Dec; 38(6):1369-76. PubMed ID: 23559419
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.